DD126929A5 - - Google Patents

Info

Publication number
DD126929A5
DD126929A5 DD195241A DD19524176A DD126929A5 DD 126929 A5 DD126929 A5 DD 126929A5 DD 195241 A DD195241 A DD 195241A DD 19524176 A DD19524176 A DD 19524176A DD 126929 A5 DD126929 A5 DD 126929A5
Authority
DD
German Democratic Republic
Application number
DD195241A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD126929A5 publication Critical patent/DD126929A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
DD195241A 1975-10-13 1976-10-12 DD126929A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB41887/75A GB1566706A (en) 1975-10-13 1975-10-13 Clavulanic acid derivatives

Publications (1)

Publication Number Publication Date
DD126929A5 true DD126929A5 (en:Method) 1977-08-24

Family

ID=10421810

Family Applications (1)

Application Number Title Priority Date Filing Date
DD195241A DD126929A5 (en:Method) 1975-10-13 1976-10-12

Country Status (28)

Country Link
US (3) US4256638A (en:Method)
JP (1) JPS5248686A (en:Method)
AR (1) AR213294A1 (en:Method)
AT (1) AT352874B (en:Method)
AU (1) AU503489B2 (en:Method)
BE (1) BE847044A (en:Method)
CA (1) CA1094563A (en:Method)
CH (2) CH634323A5 (en:Method)
DD (1) DD126929A5 (en:Method)
DE (1) DE2646003A1 (en:Method)
DK (1) DK457676A (en:Method)
ES (2) ES452361A1 (en:Method)
FI (1) FI762895A7 (en:Method)
FR (1) FR2327775A1 (en:Method)
GB (1) GB1566706A (en:Method)
GR (1) GR61674B (en:Method)
HU (1) HU175046B (en:Method)
IE (1) IE43840B1 (en:Method)
IL (1) IL50618A (en:Method)
MX (1) MX4688E (en:Method)
NL (1) NL7611206A (en:Method)
NO (3) NO763472L (en:Method)
NZ (1) NZ182190A (en:Method)
PT (1) PT65707B (en:Method)
SE (3) SE7611047L (en:Method)
SU (1) SU639454A3 (en:Method)
ZA (1) ZA765901B (en:Method)
ZM (1) ZM12276A1 (en:Method)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT363181B (de) * 1976-10-25 1981-07-10 Glaxo Lab Ltd Verfahren zur herstellung von neuen clavulansaeurederivaten
GB1604822A (en) * 1977-04-22 1981-12-16 Beecham Group Ltd N-monosubstituted-9-amino-9-deoxyclavulanic acid derivative
US4359473A (en) 1977-04-22 1982-11-16 Beecham Group Limited α-Amino deoxy clavulanic acid antibacterial agents
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
EP0005014A1 (en) * 1978-04-22 1979-10-31 Beecham Group Plc Clavulanic acid derivatives, preparation and compositions
EP0007717B1 (en) * 1978-07-29 1982-08-11 Beecham Group Plc Clavulanic acid derivatives, a process for their preparation, their use, and pharmaceutical compositions containing them
DE2966347D1 (en) * 1978-09-09 1983-12-01 Beecham Group Plc Clavulanic acid derivatives and process for their preparation
DE2966065D1 (en) * 1978-09-09 1983-09-22 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and their compositions
DE2966349D1 (en) * 1978-09-09 1983-12-01 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and their use
EP0010369B1 (en) * 1978-10-25 1983-07-20 Beecham Group Plc Clavulanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them
IL60343A0 (en) * 1979-07-02 1980-09-16 Beecham Group Ltd Clavulanic acid derivatives,their preparation and pharmaceutical compositions containing them
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
DE3066511D1 (en) * 1979-10-26 1984-03-15 Beecham Group Plc Derivatives of clavulanic acid, a process for their preparation and pharmaceutical compositions containing them
DE3169452D1 (en) * 1980-12-09 1985-04-25 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
JPS57143194A (en) * 1981-02-27 1982-09-04 Matsushita Electric Ind Co Ltd Blower
EP0062407A1 (en) * 1981-03-10 1982-10-13 Beecham Group Plc Therapeutic compounds containing beta-lactams
JPH0495698U (en:Method) * 1991-01-21 1992-08-19
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1424186A (en) * 1971-10-08 1976-02-11 Beecham Group Ltd Penicillins
US3925363A (en) * 1974-01-17 1975-12-09 Merck & Co Inc Process for epimerizing penicillin compounds, and related products
US4051132A (en) * 1974-01-23 1977-09-27 Merck & Co., Inc. Process for epimerizing beta-lactam antibiotic compounds by means of an acid quench
GB1585165A (en) * 1976-06-29 1981-02-25 Leo Pharm Prod Ltd Derivatives of 6-amidino penicillanic acid
IL54859A (en) * 1977-06-21 1982-01-31 Rech Applications Therap Derivatives of amidinopenicillanic acid,their production and pharmaceutical compositions containing them
DE2963717D1 (en) * 1978-05-06 1982-11-04 Beecham Group Plc Carbapenem derivatives, a process for their preparation and pharmaceutical compositions containing them
US4244965A (en) * 1978-06-15 1981-01-13 Beecham Group Limited Azetidinoyl ethers
US4252722A (en) * 1979-08-08 1981-02-24 Merck & Co., Inc. Process for the preparation of 6-hydroxymethyl-2-(β-aminoethylthio)-1-carbadethiapen-2-em-3-carboxylic acid
US4237051A (en) * 1979-04-19 1980-12-02 Schering Corporation Stereospecific production of 6- or 7-carbon-substituted-β-lactams
US4231928A (en) * 1979-04-24 1980-11-04 Bristol-Myers Company Antibacterial agents

Also Published As

Publication number Publication date
HU175046B (hu) 1980-05-28
US4438101A (en) 1984-03-20
ATA753476A (de) 1979-03-15
JPS612670B2 (en:Method) 1986-01-27
IL50618A (en) 1979-09-30
NO802661L (no) 1977-04-14
SE8004330L (sv) 1980-06-10
SE8004329L (sv) 1980-06-10
IE43840B1 (en) 1981-06-03
IE43840L (en) 1977-04-13
US4382084A (en) 1983-05-03
DE2646003A1 (de) 1977-04-21
AR213294A1 (es) 1979-01-15
CH639665A5 (de) 1983-11-30
DK457676A (da) 1977-04-14
NZ182190A (en) 1979-03-16
ZM12276A1 (en) 1977-07-21
NO763472L (en:Method) 1977-04-14
JPS5248686A (en) 1977-04-18
SE7611047L (sv) 1977-04-14
GB1566706A (en) 1980-05-08
CA1094563A (en) 1981-01-27
FR2327775A1 (fr) 1977-05-13
ZA765901B (en) 1977-09-28
IL50618A0 (en) 1976-12-31
FI762895A7 (en:Method) 1977-04-14
FR2327775B1 (en:Method) 1978-11-17
GR61674B (en) 1978-12-05
BE847044A (fr) 1977-04-07
AT352874B (de) 1979-10-10
PT65707A (en) 1976-11-01
NO802662L (no) 1977-04-14
CH634323A5 (de) 1983-01-31
AU503489B2 (en) 1979-09-06
ES452361A1 (es) 1978-01-01
SU639454A3 (ru) 1978-12-25
MX4688E (es) 1982-08-02
US4256638A (en) 1981-03-17
NL7611206A (nl) 1977-04-15
PT65707B (en) 1978-04-17
AU1858276A (en) 1978-04-20
ES463974A1 (es) 1978-12-16

Similar Documents

Publication Publication Date Title
JPS612670B2 (en:Method)
CH603354B5 (en:Method)
CH599798A5 (en:Method)
BG21299A1 (en:Method)
BG21520A1 (en:Method)
BG22298A1 (en:Method)
BG22466A1 (en:Method)
BG22896A1 (en:Method)
CH586579A5 (en:Method)
CH589749B5 (en:Method)
CH590550A5 (en:Method)
CH590576A5 (en:Method)
CH591012A5 (en:Method)
CH591107B5 (en:Method)
CH591683A5 (en:Method)
CH593077A5 (en:Method)
CH594090A5 (en:Method)
CH594755A5 (en:Method)
CH595056A5 (en:Method)
CH595124A5 (en:Method)
CH595266A5 (en:Method)
CH595293A5 (en:Method)
CH595889A5 (en:Method)
CH596358A5 (en:Method)
CH596462A5 (en:Method)